spacer

CDC HomeHIV/AIDS > Topics > Statistics and Surveillance > Guidelines > Integrated Guidelines for Developing Epidemiologic Profiles > Sample

Sample: Integrated Epidemiologic Profile for HIV/AIDS Prevention and Care Planning–Louisiana, 2002
space
arrow Acknowledgements
space
arrow List of Figures
space
arrow List of Tables
space
arrow Executive Summary
space
arrow Introduction
space
arrow Section 1
space
arrow Section 2
space
arrow Appendixes
space
arrow Glossary
space
arrow Abbreviations
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
Appendix A: Data Sources
spacer
spacer

Core HIV/AIDS Surveillance

AIDS Surveillance

Overview: AIDS is a reportable condition in all states and territories. Since 1993, all states and territories base their reporting practices on the 1993 CDC case definition for AIDS surveillance. The AIDS Surveillance system was established to monitor incidence of the disease and the demographic profile of AIDS cases; describe the modes of HIV transmission among persons with AIDS; guide the development and implementation of public health intervention and prevention programs; and to assist in the evaluation of the efficacy of public health interventions. AIDS surveillance data are also used to allocate resources for Titles I and II of the Ryan White CARE Act.

State and local health departments actively solicit disease reports from health care providers and laboratories. Standardized case report forms are used to collect sociodemographic information, mode of exposure, laboratory and clinical information, vital status, and referrals for treatment or services

Population: All persons who meet the 1993 CDC AIDS surveillance case definition

Strengths: This is the only source of AIDS information that is available in all areas (states). The data reflect the effect of AIDS on communities and trends of the epidemic in communities. AIDS surveillance has been determined to be >85% complete. The data include all demographic groups (age, race/ethnicity, sex).

Limitations: Because of the prolonged and variable period from infection to the development of AIDS, trends in AIDS surveillance do not represent recent HIV infections. Asymptomatic HIV-infected persons are also not represented by AIDS case data. In addition, incomplete HIV or CD4+ T-cell testing may interfere with the completeness of reporting. Further, the widespread use of HAART complicates the interpretation of AIDS case surveillance data and the estimation of the HIV/AIDS epidemic in an area. Newly reported AIDS cases may reflect treatment failures or the failure of the health care system to halt the progression of HIV infection to AIDS. AIDS cases represent late-stage HIV infections.

HIV Surveillance

Overview: Since the human immunodeficiency virus was identified and a test for HIV was licensed, CDC and other professional organizations have recommended the reporting of HIV infections to local health authorities as an integral part of AIDS surveillance activities. As part of ongoing, active HIV surveillance, state and local health departments educate providers on their reporting responsibilities, establish active surveillance sites, and establish liaisons with laboratories that perform HIV testing of samples. Moreover, HIV/AIDS surveillance programs routinely evaluate the completeness of HIV reporting and conduct follow-up on HIV cases that are of epidemiologic importance.

Population: All persons who test positive for the human immunodeficiency virus (HIV)

Strengths: HIV surveillance data represent more recent infections, compared with AIDS surveillance data. Previous evaluations have estimated that HIV infection reporting in Louisiana is >85% complete for persons who have tested positive for HIV. Consequently, HIV surveillance provides a minimum estimate of the number of persons known to be HIV infected and reported to the health department, identifies emerging patterns of transmission, and can be used to detect trends in HIV infections among populations of particular interest (e.g., children, adolescents, or women) that may not be evident from AIDS surveillance. Additionally, HIV surveillance provides a basis for establishing and evaluating linkages to the provision of prevention and early intervention services and can be used to anticipate unmet needs for HIV care.

Limitations: HIV surveillance data may underestimate the level of recently infected persons because some infected persons either do not know they are infected or have not sought testing. Persons who have tested positive at an anonymous test site and have not sought medical care, where they would be confidentially tested, are not included in HIV surveillance statistics. HIV surveillance data represent infections in jurisdictions where reporting laws for HIV are in place. HIV reporting laws differ by jurisdiction; therefore, consultation with local surveillance staff is advised on how to interpret local HIV surveillance data. Furthermore, reporting of behavioral risk information may not be complete.

Enhanced Perinatal Surveillance

Overview: Perinatal HIV/AIDS surveillance is the ongoing and systematic collection of information on HIV-infected pregnant mothers and perinatally exposed and HIV-infected children. Extensive medical record abstractions are conducted for all HIV-exposed children and their mothers, and the children are followed up until their infection status is determined. These data address the prevention of perinatal transmission, including prenatal care, HIV counseling and testing during pregnancy, and the use of zidovudine or other antiretroviral medications for pregnant mothers and neonates. The data also address questions regarding treatment issues for HIV-infected women and their children.

Population: All HIV-exposed children and their mothers

Strengths: Enhanced perinatal surveillance data provide perinatal-specific information that can be used to examine patterns in HIV testing and in the use of zidovudine in clinical practice, as well as to identify barriers to the implementation of Public Health Services guidelines. Perinatal surveillance data may also be used to help ascertain mother-infant pairs by matching data in the HIV/AIDS registry to the state birth registry each year.

Limitations: Perinatal data may underestimate the number of mother-infant pairs because some pregnant women may not know they are HIV infected and others may not have been tested for HIV. Perinatal data includes only those women who have had a positive confidential HIV test result. HIV-exposed infants must be followed up until sufficient laboratory information is available, so infants who are lost to follow-up cannot be classified as infected or not infected.

Go to Supplemental HIV/AIDS Surveillance Projects

Last Modified: July 18, 2007
Last Reviewed: July 18, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
spacer CDC Black Logospacer Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer
spacerHHS Logo